Effect of Continuous Infusion of Different Doses of Esketamine on the Bispectral Index During Sevoflurane Anesthesia: A Randomized Controlled Trial
Liyuan Ren,Jinjin Yang,Yanshuang Li,Yanping Wang
DOI: https://doi.org/10.2147/dddt.s457625
IF: 4.3188
2024-05-23
Drug Design Development and Therapy
Abstract:Liyuan Ren, Jinjin Yang, Yanshuang Li, Yanping Wang Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China Correspondence: Yanping Wang, Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, 450052, People's Republic of China, Tel +86-371-13526857360, Email Purpose: To investigate and quantify the effect of continuous esketamine infusion at different doses on the bispectral index (BIS) during sevoflurane anesthesia. Methods: A total of 120 patients scheduled for elective laparoscopic renal surgery were randomly divided into three groups. Under steady anesthesia and surgical situations, the patient was started on continuous infusion of the study drug: 0.125 mg/kg/h esketamine (group E1), 0.25 mg/kg/h esketamine (group E2), and the same volume of saline (group C). The primary outcome was changes in BIS value after 15 min (T 15 ), 30 min (T 30 ), 45 min (T 45 ), and 60 min (T 60 ) of drug infusion. The secondary outcomes were 95% spectral edge frequency (SEF95), electromyogram (EMG), heart rate (HR), and mean arterial pressure (MAP) from T 0 to T 60 . Furthermore, postoperative pain, postoperative recovery, and perioperative adverse events were evaluated. Results: Compared with group C, group E1 exhibited significant BIS elevation at T 30 –T 60 and group E2 at T 15 –T 60 ( P < 0.001). Compared with group E1, group E2 showed a more significant BIS elevation at T 15 –T 60 ( P < 0.001). The area under the curve (AUC) of BIS and SEF95 were significantly higher in group E2 than in groups C and E1 ( P < 0.05). BIS value for any of the three groups was significantly correlated with SEF95 ( P < 0.001). No significant differences were observed in the AUC of EMG, HR, and MAP among the three groups. Intraoperative remifentanil consumption and postoperative NRS of pain on movement were significantly reduced in group E2 compared with groups C and E1 ( P < 0.05). Conclusion: Continuous infusion of both 0.125 and 0.25 mg/kg/h of esketamine increased the BIS value during sevoflurane anesthesia, and the BIS value gradually stabilized with the prolongation of the infusion time. Keywords: esketamine, bispectral index, 95% spectral edge frequency, sevoflurane The bispectral index (BIS), a derivation of the original electroencephalogram (EEG), is the only FDA-approved index for evaluating anesthesia depth and is a good approach for monitoring the functional state of and changes in the cerebral cortex. 1 BIS-guided anesthesia not only minimizes intraoperative consciousness but also facilitates early postoperative recovery and reduces the risk of neurological complications. 2–5 The BIS correlates well with anesthetics that mainly act via gamma-aminobutyric acid receptors (GABARs), such as propofol, midazolam, and sevoflurane. As these drug concentrations increase, the BIS decreases in a dose-dependent manner. 6–8 However, BIS monitoring does not apply to ketamine anesthesia. Ketamine is an antagonist of the N-methyl-D-aspartate receptor (NMDAR). Previous studies have shown that a bolus of ketamine increases the BIS. 6,9 Esketamine, the dextro-isomer of ketamine, has approximately twice the affinity for NMDAR as ketamine and is characterized by quicker onset, faster elimination, fewer adverse effects, and better sedative and analgesic potency. 10,11 Previous clinical studies have demonstrated that intraoperative esketamine application decreases early pain scores, 12–14 spares opioids, 15,16 reduces hyperalgesia, 17,18 and promotes postoperative recovery in various ways. 19–24 Quantitative studies on the change in the BIS caused by continuous esketamine infusion during general anesthesia are currently lacking. When the change in the BIS is inconsistent with the real anesthesia depth, an inappropriate anesthetic dose may be administered. Thus, it is important to quantify the change in the BIS to optimize personalized anesthesia. This study aimed to explore and quantify the effect of intravenous continuous infusion of different doses of esketamine on the BIS during sevoflurane anesthesia. This study was a single-center, prospective, randomized, double-blind, controlled trial. It was approved by the Scientific Research and Clinical Trial Ethics Committee of the First Affiliated Hospital of Zhengzhou University (2023-KY-0511-001) and registered in the Chinese Clinical Trials Registry (ChiCTR23000 -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal